Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Assets Average (2016 - 2025)

Bioadaptives' Assets Average history spans 7 years, with the latest figure at $175130.5 for Q4 2025.

  • On a quarterly basis, Assets Average rose 13.62% to $175130.5 in Q4 2025 year-over-year; TTM through Dec 2025 was $175130.5, a 13.62% increase, with the full-year FY2025 number at $243893.0, up 33.32% from a year prior.
  • Assets Average hit $175130.5 in Q4 2025 for Bioadaptives, down from $198437.5 in the prior quarter.
  • Over the last five years, Assets Average for BDPT hit a ceiling of $216650.0 in Q4 2023 and a floor of $25176.5 in Q1 2023.
  • Historically, Assets Average has averaged $115426.8 across 5 years, with a median of $123386.5 in 2021.
  • Biggest five-year swings in Assets Average: crashed 85.4% in 2024 and later surged 619.92% in 2025.
  • Tracing BDPT's Assets Average over 5 years: stood at $163640.0 in 2021, then plummeted by 79.55% to $33464.5 in 2022, then skyrocketed by 547.4% to $216650.0 in 2023, then fell by 28.85% to $154139.0 in 2024, then increased by 13.62% to $175130.5 in 2025.
  • Business Quant data shows Assets Average for BDPT at $175130.5 in Q4 2025, $198437.5 in Q3 2025, and $191481.5 in Q2 2025.